Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxia Zhao

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 14, 2022
Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escapeGui Chen, Jiajun Huang, Hehua Lei, et al.
Chemical Science|July 26, 2019
Construction and interconversion of anion-coordination-based ('aniono') grids and double helicates modulated by counter-cationsXiaoxia Fan, Dan Zhang, Shiyu Jiang, et al.
Transboundary and Emerging Diseases|April 30, 2025
Characterization of Pseudorabies Virus Associated with Severe Respiratory and Neuronal Signs in Old PigsHongjian Chen, Jie Fan, Xiuxiu Sun, et al.
Genome Biology|October 23, 2023
Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome miceZongyi Yi, Yanxia Zhao, Zexuan Yi, et al.
British Journal of Cancer|October 5, 2024
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancerYao Sun, Zhenzhen Yin, Shuang Li, et al.
The Journal of Experimental Medicine|March 15, 2021
Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasionXiaoyuan Huang, Xiangyang Bai, Yang Cao, et al.
The Journal of Experimental Medicine|February 24, 2010
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasionXiaoyuan Huang, Xiangyang Bai, Yang Cao, et al.
Journal of Evidence-Based Medicine|June 25, 2026
Expert Consensus on the Combined Application of Radiotherapy and Novel Systemic Agents in Breast Cancer TreatmentJie Lan, Wenyi Zhou, Qiufan Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma modelsYingchao Zhao, Pinan Liu, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2019
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stromaYanxia Zhao, Jinghong Cao, Alexander Melamed, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 14, 2022
Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escapeGui Chen, Jiajun Huang, Hehua Lei, et al.
Chemical Science|July 26, 2019
Construction and interconversion of anion-coordination-based ('aniono') grids and double helicates modulated by counter-cationsXiaoxia Fan, Dan Zhang, Shiyu Jiang, et al.
Transboundary and Emerging Diseases|April 30, 2025
Characterization of Pseudorabies Virus Associated with Severe Respiratory and Neuronal Signs in Old PigsHongjian Chen, Jie Fan, Xiuxiu Sun, et al.
Genome Biology|October 23, 2023
Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome miceZongyi Yi, Yanxia Zhao, Zexuan Yi, et al.
British Journal of Cancer|October 5, 2024
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancerYao Sun, Zhenzhen Yin, Shuang Li, et al.
The Journal of Experimental Medicine|March 15, 2021
Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasionXiaoyuan Huang, Xiangyang Bai, Yang Cao, et al.
The Journal of Experimental Medicine|February 24, 2010
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasionXiaoyuan Huang, Xiangyang Bai, Yang Cao, et al.
Journal of Evidence-Based Medicine|June 25, 2026
Expert Consensus on the Combined Application of Radiotherapy and Novel Systemic Agents in Breast Cancer TreatmentJie Lan, Wenyi Zhou, Qiufan Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma modelsYingchao Zhao, Pinan Liu, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2019
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stromaYanxia Zhao, Jinghong Cao, Alexander Melamed, et al.
Pageof 25